-
Study aim
-
The effect of tDCS along with postural training on static and dynamic balance on patients with diabetic neuropathy
-
Design
-
A controlled, double-blind, single-center, randomized clinical trial with 39 participants in 3 groups of 13.
-
Settings and conduct
-
Neuromuscular Rehabilitation Research Center
Patients receive balance training for 4 weeks, 3 sessions per week, in 3 groups (with cerebellar tDCS stimulation, with Sham-tDCS stimulation, and alone).
-
Participants/Inclusion and exclusion criteria
-
Include criteria: Age 40-60 years; Patients who have symptoms of neuropathy such as tingling or numbness in the soles of the feet; Patients who receive a Berg scale score of less than 45; Patients who are classified as moderate or severe according to the Toronto Clinical Scoring System
Exclusion criteria: Other neurological diseases (multiple sclerosis, history of stroke, Parkinson's, myelopathy, cerebellar ataxia); The patient's use of chemotherapy drugs that induced neuropathy; Mild neuropathy severity based on the Toronto Clinical Neuropathy Scale (score less than 8); Patients taking insulin
-
Intervention groups
-
Intervention group1: In this group according to the protocol, patients receive balance exercises on the device for 20 minutes simultaneously with cerebellar tDCS stimulation.
Intervention group2: In this group according to the protocol, patients receive balance exercises on the device for 20 minutes simultaneously with Sham-tDCS cerebellar stimulation.
Control group: In this group according to the protocol, patients receive balance exercises alone for 4 weeks, 3 sessions per week, and this is only for comparison with the intervention group.
-
Main outcome variables
-
Barge Balance Scale(BBS); Anterior-posterior stability indices; Overall stability index; Mediolateral stability index(internal - external)